Spectrum and treatment of anaerobic infections

被引:93
作者
Brook, Itzhak [1 ]
机构
[1] Georgetown Univ, Sch Med, Dept Pediat, Washington, DC 20007 USA
关键词
Anaerobes; Infection; Bacteroides fragilis; Antimicrobial resistance; Antibiotics; CHRONIC MAXILLARY SINUSITIS; BACTEROIDES-FRAGILIS GROUP; LACTAMASE-PRODUCING BACTERIA; PELVIC-INFLAMMATORY-DISEASE; SUPPURATIVE OTITIS-MEDIA; PREVOTELLA-INTERMEDIA; IMMUNE-RESPONSE; FUSOBACTERIUM-NUCLEATUM; RECURRENT TONSILLITIS; BETA-LACTAMASE;
D O I
10.1016/j.jiac.2015.10.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Anaerobes are the most predominant components of the normal human skin and mucous membranes bacterial flora, and are a frequent cause of endogenous bacterial infections. Anaerobic infections can occur in all body locations: the central nervous system, oral cavity, head and neck, chest, abdomen, pelvis, skin, and soft tissues. Treatment of anaerobic infection is complicated by their slow growth in culture, by their polymicrobial nature and by their growing resistance to antimicrobials. Antimicrobial therapy is frequently the only form of therapy needed, whereas in others it is an important adjunct to drainage and surgery. Because anaerobes generally are isolated mixed with aerobes, the antimicrobial chosen should provide for adequate coverage of both. The most effective antimicrobials against anaerobes are: metronidazole, the carbapenems (imipenem, meropenem, doripenem, ertapenem), chloramphenicol, the combinations of a penicillin and a beta-lactamase inhibitors (ampicillin or ticarcillin plus clavulanate, amoxicillin plus sulbactam, piperacillin plus tazobactam), tigecycline, cefoxitin and clindamycin. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 92 条
[1]   Propionibacterium acnes: from Commensal to Opportunistic Biofilm-Associated Implant Pathogen [J].
Achermann, Yvonne ;
Goldstein, Ellie J. C. ;
Coenye, Tom ;
Shirtliff, Mark E. .
CLINICAL MICROBIOLOGY REVIEWS, 2014, 27 (03) :419-440
[2]   Susceptibility trending of blood isolates of the Bacteroides fragilis group over a 12-year period to clindamycin, ampicillin-sulbactam, cefoxitin, imipenem, and metronidazole [J].
Aldridge, KE ;
Sanders, CV .
ANAEROBE, 2002, 8 (06) :301-305
[3]   Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species [J].
Aldridge, KE ;
Ashcraft, D ;
Cambre, K ;
Pierson, CL ;
Jenkins, SG ;
Rosenblatt, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1238-1243
[4]   BACTERIOLOGY OF ASPIRATION PNEUMONIA [J].
BARTLETT, JG ;
GORBACH, SL ;
FINEGOLD, SM .
AMERICAN JOURNAL OF MEDICINE, 1974, 56 (02) :202-207
[5]  
Bennion RS, 1990, CLIN THER SC, V12, P31
[6]   Diagnosis and management of brain abscess and subdural empyema [J].
Bernardini G.L. .
Current Neurology and Neuroscience Reports, 2004, 4 (6) :448-456
[7]  
BOHNEN JMA, 1988, ARCH SURG-CHICAGO, V123, P225
[8]   Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery [J].
Bratzler, Dale W. ;
Dellinger, E. Patchen ;
Olsen, Keith M. ;
Perl, Trish M. ;
Auwaerter, Paul G. ;
Bolon, Maureen K. ;
Fish, Douglas N. ;
Napolitano, Lena M. ;
Sawyer, Robert G. ;
Slain, Douglas ;
Steinberg, James P. ;
Weinstein, Robert A. .
SURGICAL INFECTIONS, 2013, 14 (01) :73-156
[9]   Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with infectious mononucleosis [J].
Brook, I ;
DeLeyva, F .
JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 44 (02) :131-134
[10]  
BROOK I, 1983, ARCH OTOLARYNGOL, V109, P818